스마트 의료기기 시장 보고서 : 제품 유형, 유통 채널, 용도, 최종사용자, 지역별(2025-2033년)

The global smart medical devices market size reached USD 45.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 82.0 Billion by 2033, exhibiting a growth rate (CAGR) of 6.33% during 2025-2033. The growing integration of the Internet of Things (IoT) in the healthcare sector, rising popularity of remote patient monitoring and personalized medication, and increasing occurrence of various chronic diseases are some of the major factors propelling the market.

Smart medical devices rely on advanced technologies and connectivity features to enhance healthcare delivery, patient monitoring, diagnosis, and treatment. They comprise wearable devices, which are small electronic devices worn on the body that monitor vital signs, activity levels, and other health-related parameters. They leverage sensors, data analysis, wireless communication, and the Internet of Things (IoT) capabilities to collect and transmit real-time data and improve the efficiency and effectiveness of medical interventions. They enhance patient quality of life, reduce the risk of medical emergencies, and provide long-term monitoring without constant patient interaction.

At present, the increasing demand for smart medical devices as they improve patient outcomes by providing healthcare professionals with access to accurate and up-to-date patient data, leading to more informed decision-making, is impelling the growth of the market. Besides this, the rising adoption of patient-centric care by providing real-time health data, personalized feedback, and self-management tools is contributing to the growth of the market. In addition, the growing construction of hospitals, nursing homes, and clinics around the world to provide quality healthcare services to patients is offering a favorable market outlook. Apart from this, increasing technological advancements in the manufacturing of various smart medical devices to improve their functionalities are supporting the growth of the market. additionally, the rising employment of smart medical devices as they promote patient engagement, adherence to treatment plans, and better patient-provider communication is bolstering the growth of the market.

Smart Medical Devices Market Trends/Drivers:

Rising integration of Internet of Things (IoT) in healthcare facilities

At present, there is an increase in the integration of the Internet of Things (IoT) in the healthcare sector as it streamlines processes and improves operational efficiency. It also helps healthcare facilities optimize resource allocation, reduce errors, and enhance overall operational efficiency, leading to cost savings and improved patient care. IoT devices generate extensive amounts of data, which can be analyzed in real-time to derive actionable insights. Besides this, by leveraging advanced analytics and artificial intelligence (AI), healthcare providers can gain valuable insights into patient health trends, disease management, and treatment effectiveness. Moreover, IoT is widely incorporated into smart medical devices, which empower patients to actively participate in their healthcare management.

Increasing popularity of remote patient monitoring

Remote patient monitoring allows individuals to monitor their health from the comfort of their own homes, eliminating the need for frequent visits to healthcare facilities. It reduces travel time, waiting room visits, and overall healthcare-related inconvenience, leading to better patient satisfaction. It expands access to healthcare, especially for individuals in remote or underserved areas. It enables patients to connect with healthcare providers and receive quality care regardless of their geographic location. It enables healthcare providers to monitor the health of patients in real-time and detect any deviations or anomalies promptly by relying on smart medical devices which collect the data and convey it to the healthcare providers.

Increasing occurrence of chronic disorders among the masses

At present, there is an increase in the occurrence of chronic disorders due to sedentary behaviors, including prolonged sitting, reduced physical activity, and unhealthy dietary habits. These lifestyle factors contribute to the development of chronic ailments, such as obesity, diabetes, and cardiovascular conditions. Apart from this, poor dietary choices, including high consumption of processed foods, sugary beverages, and food products with high saturated fats, are contributing to the development of chronic diseases. The increasing occurrence of chronic diseases is also propelling the hospitalization rates and utilization of various smart medical devices. Smart medical devices are improving diagnostic methods and are leading to better detection and diagnosis of chronic diseases. Furthermore, with enhanced screening and early detection using smart medical devices, more cases of chronic disorders are being identified and controlled.

Smart Medical Devices Industry Segmentation:

Breakup by Product Type:

• Diagnostic and Monitoring
• Blood Glucose Monitors
• Heart Rate Monitors
• Pulse Oximeters
• Blood Pressure Monitors
• Breath Analyzer
• Other Diagnostic Monitoring Products
• Therapeutic Devices
• Portable Oxygen Concentrators and Ventilators
• Insulin Pumps
• Hearing Aid
• Other Therapeutic Devices

Diagnostic and monitoring dominate the market

Diagnostic and monitoring devices play a crucial role in healthcare by aiding in the diagnosis, monitoring, and management of various medical conditions. These devices provide healthcare professionals with valuable insights into the health status of patients, allowing for accurate diagnoses, personalized treatment plans, and proactive interventions. They provide healthcare professionals with essential information about heart rate, oxygen saturation levels, blood pressure, and body temperature, helping in the assessment of overall health and detecting any abnormalities. They also assist in the diagnosis of various conditions, such as fractures, tumors, infections, and abnormalities in organs or tissues. They are used to detect irregularities in heart rhythm, identify heart disorders, such as arrhythmias or ischemic events, and assess the effectiveness of cardiac treatments.

Breakup by Distribution Channel:

• Pharmacies
• Online
• Others

Online holds the largest share in the market

Online shopping provides convenience and accessibility to a wide range of smart medical devices. Patients and healthcare professionals can browse and purchase devices from the comfort of their homes or offices without the need to visit physical stores. This is particularly beneficial for patients with mobility limitations, those in remote areas, or busy healthcare professionals who prefer the ease of online shopping. Online platforms offer a vast selection of smart medical devices from various manufacturers and brands, and individuals have access to various options, allowing them to compare features, specifications, and prices before making a purchase. Furthermore, online retailers also have greater inventory capacity, ensuring the availability of different models and variations of smart medical devices.

Breakup by Application:

• Oncology
• Diabetes
• Auto-Immune Disorders
• Infectious Diseases
• Others

Smart medical devices aid in the early detection and diagnosis of cancer. Advanced imaging technologies, such as magnetic resonance imaging (MRI), computed tomography (CT) scanners, and positron emission tomography (PET) scanners, provide detailed images of tumors and their characteristics, helping in accurate staging. They also assist in treatment planning and delivery for oncology patients.

Smart medical devices have transformed diabetes management by providing individuals suffering from diabetes and healthcare professionals with advanced tools to monitor blood glucose levels, track medication adherence, and make informed decisions about treatment.

Smart medical devices play a crucial role in the rapid diagnosis of infectious diseases and enable healthcare professionals to quickly detect pathogens and identify specific infections. They provide timely results, allowing for immediate treatment initiation and appropriate infection control measures.

Breakup by End User:

• Hospitals and Clinics
• Home-Care Setting
• Others

Smart medical devices are revolutionizing the healthcare landscape, playing a pivotal role in hospitals and clinics across various applications. These advanced devices provide healthcare professionals with the tools and technologies necessary to deliver efficient, accurate, and patient-centered care. In hospitals and clinics, smart medical devices are extensively utilized in electronic health records (EHR) systems to ensure seamless data exchange and integration, enabling healthcare providers to access real-time patient information and enhance care coordination.

Smart medical devices are playing an increasingly vital role in home care settings, enabling individuals to receive high-quality healthcare services in the comfort of their own homes. These devices empower patients, caregivers, and healthcare providers by providing advanced monitoring, diagnostic, and treatment tools. In the realm of home care, smart medical devices support remote patient monitoring, allowing healthcare professionals to track vital signs, symptoms, and medication adherence from a distance.

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

North America exhibits a clear dominance, accounting for the largest smart medical devices market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest market share since the region has a well medical infrastructure. The rising construction of various hospitals, clinics, and nursing homes to provide quality healthcare services is bolstering the growth of the market.

Another contributing aspect is the growing demand for automation in the healthcare sector to improve efficiency and reduce errors. Besides this, the increasing demand for minimally invasive (MI) surgical procedures to reduce the duration of hospital stays and post-operative scarring is bolstering the growth of the market.

Asia Pacific is estimated to expand further in this domain due to the rising occurrence of various chronic disorders among the masses. Apart from this, the increasing healthcare expenditures among the masses is propelling the growth of the market.

Competitive Landscape:

Key market players are investing in research activities to develop innovative smart medical devices with enhanced functionalities. They are focusing on improving device performance, reliability, connectivity, and user experience by integrating advanced technologies, including artificial intelligence (AI), data analytics, and machine learning (ML), to enable more accurate diagnostics, personalized treatment, and proactive healthcare management. Top companies are forming strategic partnerships and collaborations with other organizations to leverage complementary expertise and expand their market presence. They are also focusing on accessing new resources, technologies, and customer bases, fostering business growth. Top companies are expanding their geographical footprint and increasing their market share in new regions.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

• Abbott Laboratories
• Activinsights Ltd
• Apple Inc.
• Debiotech SA
• Enable Injections
• Fitbit LLC (Google LLC)
• Koninklijke Philips N.V.
• Medtronic PLC
• NeuroMetrix Inc.
• Omron Healthcare Co Ltd (Omron Corporation)
• Sonova Holding AG
• Sotera Wireless Inc.
• VitalConnect

Key Questions Answered in This Report

• 1.What was the size of the global smart medical devices market in 2024?
• 2.What is the expected growth rate of the global smart medical devices market during 2025-2033?
• 3.What are the key factors driving the global smart medical devices market?
• 4.What has been the impact of COVID-19 on the global smart medical devices market?
• 5.What is the breakup of the global smart medical devices market based on the product type?
• 6.What is the breakup of the global smart medical devices market based on the distribution channel?
• 7.What are the key regions in the global smart medical devices market?
• 8.Who are the key players/companies in the global smart medical devices market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Smart Medical Devices Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product Type

• 6.1 Diagnostic and Monitoring
  • 6.1.1 Market Trends
  • 6.1.2 Key Segments
    • 6.1.2.1 Blood Glucose Monitors
    • 6.1.2.2 Heart Rate Monitors
    • 6.1.2.3 Pulse Oximeters
    • 6.1.2.4 Blood Pressure Monitors
    • 6.1.2.5 Breath Analyzer
    • 6.1.2.6 Other Diagnostic Monitoring Products
  • 6.1.3 Market Forecast
• 6.2 Therapeutic Devices
  • 6.2.1 Market Trends
  • 6.2.2 Key Segments
    • 6.2.2.1 Portable Oxygen Concentrators and Ventilators
    • 6.2.2.2 Insulin Pumps
    • 6.2.2.3 Hearing Aid
    • 6.2.2.4 Other Therapeutic Devices
  • 6.2.3 Market Forecast

7 Market Breakup by Distribution Channel

• 7.1 Pharmacies
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Online
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Others
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by Application

• 8.1 Oncology
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Diabetes
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Auto-Immune Disorders
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Infectious Diseases
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Others
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast

9 Market Breakup by End User

• 9.1 Hospitals and Clinics
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Home-Care Setting
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Others
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Abbott Laboratories
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
    • 15.3.1.3 Financials
    • 15.3.1.4 SWOT Analysis
  • 15.3.2 Activinsights Ltd
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
  • 15.3.3 Apple Inc.
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
    • 15.3.3.3 Financials
    • 15.3.3.4 SWOT Analysis
  • 15.3.4 Debiotech SA
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
  • 15.3.5 Enable Injections
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
  • 15.3.6 Fitbit LLC (Google LLC)
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
  • 15.3.7 Koninklijke Philips N.V.
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
    • 15.3.7.3 Financials
    • 15.3.7.4 SWOT Analysis
  • 15.3.8 Medtronic PLC
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
    • 15.3.8.3 Financials
    • 15.3.8.4 SWOT Analysis
  • 15.3.9 NeuroMetrix Inc.
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
    • 15.3.9.3 Financials
  • 15.3.10 Omron Healthcare Co Ltd (Omron Corporation)
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
    • 15.3.10.3 SWOT Analysis
  • 15.3.11 Sonova Holding AG
    • 15.3.11.1 Company Overview
    • 15.3.11.2 Product Portfolio
  • 15.3.12 Sotera Wireless Inc.
    • 15.3.12.1 Company Overview
    • 15.3.12.2 Product Portfolio
  • 15.3.13 VitalConnect
    • 15.3.13.1 Company Overview
    • 15.3.13.2 Product Portfolio